INSIGHTS

The current and future value of mRNA vaccines and therapeutics

 WHITE PAPER

With experience in both chemistry and biologics, Curia is uniquely positioned to provide mRNA drug development solutions spanning discovery and engineering, mRNA drug substance formulation, and fill-finish and manufacturing of lipids and nucleosides.

Download our white paper for insights on:

• Seven considerations when combining early- and late-stage process development for fast-track drugs
• Late-stage development to commercialization
• When it comes to speed, Integrated process development counts